- Home
- FTI vs PEN Comparison
FTI vs PEN Comparison
Compare FTI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTI | PEN |
|---|---|---|
| Founded | 1884 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 13.2B |
| IPO Year | 2016 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FTI | PEN |
|---|---|---|
| Price | $62.73 | $335.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | $61.42 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 4.1M | 566.6K |
| Earning Date | 05-25-2026 | 05-26-2026 |
| Dividend Yield | ★ 0.32% | N/A |
| EPS Growth | 20.42 | ★ 1155.56 |
| EPS | 2.30 | ★ 4.52 |
| Revenue | ★ $9,932,600,000.00 | $1,403,665,000.00 |
| Revenue This Year | $8.54 | $14.20 |
| Revenue Next Year | $5.39 | $13.60 |
| P/E Ratio | ★ $27.17 | $74.11 |
| Revenue Growth | 9.35 | ★ 17.50 |
| 52 Week Low | $22.12 | $221.26 |
| 52 Week High | $68.29 | $362.41 |
Technical Indicators
Market Signals| Indicator | FTI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.35 | 43.41 |
| Support Level | $58.67 | $302.19 |
| Resistance Level | $68.29 | $344.07 |
| Average True Range (ATR) | 2.26 | 2.39 |
| MACD | -0.74 | -0.93 |
| Stochastic Oscillator | 28.79 | 18.85 |
Price Performance
Historical ComparisonAbout FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.